Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where George K. Turi is active.

Publication


Featured researches published by George K. Turi.


Archives of Biochemistry and Biophysics | 2002

Sulfhydryl oxidases: emerging catalysts of protein disulfide bond formation in eukaryotes.

Colin Thorpe; Karen L. Hoober; Sonali Raje; Nicole M. Glynn; Joan Burnside; George K. Turi; Donald L. Coppock

Members of the Quiescin-sulfhydryl oxidase (QSOX) family utilize a thioredoxin domain and a small FAD-binding domain homologous to the yeast ERV1p protein to oxidize sulfhydryl groups to disulfides with the reduction of oxygen to hydrogen peroxide. QSOX enzymes are found in all multicellular organisms for which complete genomes exist and in Trypanosoma brucei, but are not found in yeast. The avian QSOX is the best understood enzymatically: its preferred substrates are peptides and proteins, not monothiols such as glutathione. Mixtures of avian QSOX and protein disulfide isomerase catalyze the rapid insertion of the correct disulfide pairings in reduced RNase. Immunohistochemical studies of human tissues show a marked and highly localized concentration of QSOX in cell types associated with heavy secretory loads. Consistent with this role in the formation of disulfide bonds, QSOX is typically found in the cell in the endoplasmic reticulum and Golgi and outside the cell. In sum, this review suggests that QSOX enzymes play a significant role in oxidative folding of a large variety of proteins in a wide range of multicellular organisms.


Gastrointestinal Endoscopy | 2012

High yield of same-session EUS-guided liver biopsy by 19-gauge FNA needle in patients undergoing EUS to exclude biliary obstruction

Stavros N. Stavropoulos; Gene Y. Im; Zahra Jlayer; Michael D. Harris; Teodor C. Pitea; George K. Turi; Peter Malet; David Friedel; James H. Grendell

BACKGROUND EUS-guided liver biopsy by Trucut yields variable specimen adequacy at high cost, limiting its utility. A modified EUS-guided technique with reliable adequacy could be a viable alternative to standard techniques in cost-effective clinical settings. OBJECTIVE To describe our experience with EUS-guided liver biopsy by 19-gauge FNA, non-Trucut, needle in a cost-effective setting: patients with abnormal liver test results of unclear etiology referred for EUS to exclude biliary obstruction in whom an unrevealing EUS would have prompted a next-step liver biopsy by the referring physician. DESIGN Prospective case series. SETTING Tertiary-care teaching hospital. PATIENTS Consecutive patients with abnormal liver tests referred for EUS. INTERVENTIONS EUS-guided liver biopsy by 19-gauge FNA needle (non-Trucut). MAIN OUTCOME MEASUREMENTS Diagnostic yield, specimen adequacy, and complications. An adequate specimen was defined as a length of 15 mm or longer and 6 or more complete portal tracts (CPTs). RESULTS Between July 2008 and July 2011, 22 of 31 consecutive patients meeting inclusion criteria underwent unrevealing EUS with same-session EUS-guided liver biopsy by 19-gauge FNA needle. A median of 2 FNA passes (range 1-3) yielded a median specimen length of 36.9 mm (range 2-184.6 mm) with a median of 9 CPTs (range 1-73 CPTs). EUS-guided liver biopsies yielded a histologic diagnosis and adequate specimens in 20 of 22 patients (91%). Expanded experience led to improved specimen adequacy. There were no complications. LIMITATION Small study size. CONCLUSIONS EUS-guided liver biopsy by using a 19-gauge FNA needle appears to be feasible and safe and provides excellent diagnostic yield and specimen adequacy.


The Journal of Rheumatology | 2011

Temporal Small-Vessel Inflammation in Patients with Giant Cell Arteritis: Clinical Course and Preliminary Immunohistopathologic Characterization

Elise Belilos; Judy Maddox; Robert M. Kowalewski; Jolanta Kowalewska; George K. Turi; Lucien E. Nochomovitz; Yaqoot Khan; Steven E. Carsons

Objective. To investigate the occurrence, clinical correlates, and immunohistochemical phenotype of temporal small-vessel inflammation (TSVI) in temporal artery biopsies from patients presenting with clinical features of giant cell arteritis (GCA). Methods. We retrospectively reviewed 41 temporal artery biopsy specimens for the presence of inflammatory infiltrates in small vessels external to the temporal artery adventitia (TSVI); 33 had sufficient clinical and pathological data for detailed analysis. Clinical and laboratory features at presentation and corticosteroid treatment patterns of patients with isolated TSVI were compared to those of patients with positive and negative biopsies. The cellular composition of the infiltrates was further characterized by immunohistochemistry. Results. Twenty-three (70%) specimens had evidence of TSVI including 10 with concurrent GCA and 13 (39%) with isolated TSVI. TSVI was found in all positive temporal artery biopsies. The proportion of macrophages and of lymphocyte subpopulations differed between infiltrates observed in TSVI and those of the main temporal artery wall. Initial erythrocyte sedimentation rate (ESR) was similar in the TSVI and positive biopsy groups and was significantly higher than in the negative biopsy group. Patients with isolated TSVI more often had symptoms of polymyalgia rheumatica compared to the positive biopsy group. Patients with TSVI received corticosteroid doses that were intermediate between patients with positive and those with negative biopsies. Conclusion. A significant number of patients with clinical features of GCA demonstrated isolated TSVI. Differences in the clinical presentation and cellular composition suggest that TSVI may represent a subset of GCA and should be considered in the interpretation of temporal artery biopsies and treatment decisions.


Experimental Biology and Medicine | 2016

Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux.

Iryna Voloshyna; Isaac Teboul; Michael J. Littlefield; Nm Siegart; George K. Turi; Melissa Fazzari; Steven E. Carsons; Joshua DeLeon; Allison B. Reiss

Resveratrol is a bioactive molecule used in dietary supplements and herbal medicines and consumed worldwide. Numerous investigations by our group and others have indicated cardioprotective and anti-inflammatory properties of resveratrol. The present study explored potential atheroprotective actions of resveratrol on cholesterol efflux in cultured human macrophages exposed to plasma from systemic lupus erythematosus (SLE) patients. These results were confirmed in ApoE−/−Fas−/− double knockout mice, displaying a lupus profile with accelerated atherosclerosis. Resveratrol treatment attenuated atherosclerosis in these mice. THP-1 human macrophages were exposed to 10% pooled or individual plasma from patients who met diagnostic criteria for SLE. Expression of multiple proteins involved in reverse cholesterol transport (ABCA1, ABCG1, SR-B1, and cytochrome P450 27-hydroxylase) was assessed using QRT-PCR and Western blotting techniques. Ten-week-old ApoE−/−Fas−/− double knockout mice (n = 30) were randomly divided into two equal groups of 15, one of which received 0.01% resveratrol for 10 consecutive weeks. Atherosclerosis progression was evaluated in murine aortas. Bone marrow-derived macrophages (BMDM) were cultured and expression of cholesterol efflux proteins was analyzed in each group of mice. Our data indicate that inhibition of cholesterol efflux by lupus plasma in THP-1 human macrophages is rescued by resveratrol. Similarly, administration of resveratrol in a lupus-like murine model reduces plaque formation in vivo and augments cholesterol efflux in BMDM. This study presents evidence for a beneficial role of resveratrol in atherosclerosis in the specific setting of SLE. Therefore, resveratrol may merit investigation as an additional resource available to reduce lipid deposition and atherosclerosis in humans, especially in such vulnerable populations as lupus patients.


Advances in Skin & Wound Care | 2016

Major Histopathologic Diagnoses of Chronic Wounds.

George K. Turi; Virginia Donovan; Julie DiGregorio; Theresa M. Criscitelli; Benjamin Kashan; Stephan Barrientos; Jose Ramon Balingcongan; Scott Gorenstein; Harold Brem

PURPOSE:To clarify the histopathology of acute osteomyelitis, chronic osteomyelitis, primary vasculitis, and secondary-type vasculitis. TARGET AUDIENCE:This continuing education activity is intended for physicians and nurses with an interest in skin and wound care. OBJECTIVES/OUTCOMES:After participating in this educational activity, the participant should be better able to:1. Describe the parameters and significance of this study.2. Identify chronic wound diagnosis and treatment.3. Differentiate the histopathology of osteomyelitis and vasculitis. ABSTRACTOBJECTIVE: The presence of a chronic wound can result in significant morbidity/mortality. Understanding the pathological alterations of wound tissue that are refractory to standard wound therapy is essential for effective wound management and healing. The authors describe 4 wound etiologies, specifically, acute osteomyelitis, chronic osteomyelitis, primary vasculitis, and secondary-type vasculitis.SETTING: A tertiary care hospital.DESIGN: A retrospective review of 1392 wound operations performed during a 24-month period at a tertiary care hospital was conducted. Tissue specimens reviewed included soft tissue infections of the lower extremity, sacrum, hip/pelvis, trunk, perineum, and buttocks.MAIN RESULTS: Acute osteomyelitis is defined as bone tissue with a predominance of polymorphonuclear leukocytes, evidence of osteoclast bone resorption with scalloping of the cortical bone edges, and bone detritus. Chronic osteomyelitis is defined as bone tissue with a significant amount of fibrosis surrounding devitalized tissue and heavy infiltration of lymphocytes and plasma cells. Primary-type vasculitis is defined primarily as inflammation and necrosis of blood vessel walls. In cutaneous lesions of granulomatosis with polyangiitis, ulceration with numerous inflammatory granulomas is seen in the papillary dermis. Secondary vasculitis is defined by vessel wall infiltration by inflammatory cells and fibrinoid necrosis of the small vessel wall.CONCLUSIONS: Pathologies of these 4 types of wounds can complicate standard algorithms designed for diagnosis and treatment, and accurate diagnosis through histopathologic analysis can help tailor targeted treatment.


International Journal of Dermatology | 2014

Long‐standing exophytic mass in the right infratemporal region

Sambit K. Mohanty; Dinesh Pradhan; Preeti Diwaker; Ashmita Gami; Iman T. Hanna; Alan M. Freedman; George K. Turi

An 80-year-old woman presented with a long-standing exophytic mass in the right temple region (Fig. 1). The mass had been increasing in size slowly and progressively over the last eight years. There was no history of pain or bleeding. She had no family history of cancer. On physical examination, the mass was 5 cm in maximum dimension, lobulated, and was tan-pink to red in color. It was soft to firm in consistency and was non-tender. (a) (b)


Journal of Cancer Research and Therapeutics | 2015

Myxoid degeneration of appendix wall: An entity in search of identity: Report of two cases.

Laleh Hakima; Sambit K. Mohanty; Dinesh Pradhan; Aurobinda Samal; Niharika Pattnaik; George K. Turi

Myxoid degeneration of the appendix wall without accompanying acute appendicitis (AA) is rare. We report two cases of myxoid degeneration of appendix associated with appendiceal adhesions. Both the cases showed marked splitting and disruption of smooth muscle fibers of muscularis propria by abundant myxoid ground substance and dispersed degenerated hypereosinophilic myofibers with pyknotic nuclei. Scattered degenerated myocytes with vacuolated cytoplasm were also identified. Focal serosal fibrosis was observed in both cases. We reviewed other pathologic processes that involve the appendix such as fibrous obliteration, AA, and appendiceal mucinous neoplasm (AMN) and conclude that the constellations of pathologic findings described herein are unique. Nonneoplastic dissecting myxoid degeneration of the appendix muscularis propria has not been reported in the pathology literature to date. The pathologic nature of appendiceal mucinous stromal change remains unclear; however, we hypothesize that the lesion occurs as a consequence of traction related injury to the appendix.


Journal of Clinical Microbiology | 2012

Answer to June 2012 Photo Quiz

Burke A. Cunha; Jean E. Hage; George K. Turi

Answer: Measles. Although the patient had received his childhood immunizations, he had been potentially exposed to an adult with measles 2 weeks prior to admission while visiting a friend. Measles IgM and IgG titers were ordered, but the results were not immediately available. Because of the potential measles exposure and findings compatible with measles, i.e., conjunctival suffusion and maculopapular rash, he was placed on airborne precautions until the diagnosis of measles could be established or ruled out. Consistent with measles were thrombocytopenia, atypical lymphocytes, mildly decreased serum sodium, and an elevated serum transaminase level (2–4). Against the diagnosis of measles were his previous immunization history and the profuse and prolonged watery diarrhea as a major manifestation of measles.


Journal of Clinical Microbiology | 2012

Photo Quiz: A 45-Year-Old Male with Rash, Fever, and Diarrhea

Burke A. Cunha; Jean E. Hage; George K. Turi

A 45-year old male was admitted with profuse watery diarrhea, rash, and a fever. His present illness began approximately 1 week prior to admission, when he noticed a fever, chills, headache, cough, nausea, vomiting, and profuse watery diarrhea. He also developed a rash that began on his face and


Clinical Imaging | 2006

Radiology–Pathology Conference: sclerosing hemangioma of the lung

Jeremy Neuman; Alex Rosioreanu; Allan Schuss; George K. Turi; Elizabeth Yung; Terence K. Trow; Lewis Williams; Douglas S. Katz

Collaboration


Dive into the George K. Turi's collaboration.

Top Co-Authors

Avatar

Douglas S. Katz

Winthrop-University Hospital

View shared research outputs
Top Co-Authors

Avatar

Burke A. Cunha

Winthrop-University Hospital

View shared research outputs
Top Co-Authors

Avatar

Jean E. Hage

Winthrop-University Hospital

View shared research outputs
Top Co-Authors

Avatar

Alex Rosioreanu

Winthrop-University Hospital

View shared research outputs
Top Co-Authors

Avatar

Allan Schuss

Winthrop-University Hospital

View shared research outputs
Top Co-Authors

Avatar

Arzu Buyuk

Winthrop-University Hospital

View shared research outputs
Top Co-Authors

Avatar

Dinesh Pradhan

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar

Elizabeth Yung

Winthrop-University Hospital

View shared research outputs
Top Co-Authors

Avatar

Gene Y. Im

Winthrop-University Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge